Tesamorelin

Tesamorelin

$39.90

GHRH analogue · visceral fat reduction · IGF-1 elevation

Specification: 2 mg / vial

Availability: Usually ships within 2 days.

SKU: TSM2 Category:
Research product information

Tesamorelin

Structured product, pathway, quality-documentation, and laboratory-handling information.

Product overview

Product
Tesamorelin
SKU
TSM2
Compound
Tesamorelin
Strength
2 mg / vial
Product format
Lyophilised peptide
Quantity per vial
10 mg
Category
Stock
Availability shown at checkout

Compound profile

Receptor or pathway
GHRH-related pathway investigation
Common areas of scientific investigation
  • Growth-hormone axis studies
  • Metabolic pathway studies
  • Endocrine signalling investigation
Known status
Studied in clinical and translational study contexts.
Important limitations of available evidence
Findings depend on design and population; investigational-use interpretation requires caution.

Quality documentation

COA details are published when valid batch documentation is available. No certificate is currently assigned to this SKU.

View all available certificates →

Storage and laboratory handling

Unopened storage
Follow product lot storage and handling documentation.
Light exposure
Protect from direct light exposure.
Temperature range
Use supplier and batch certificate temperature guidance.
Lyophilised
Yes
  • Maintain sterile reconstitution methods.
  • Track handling and storage in laboratory records.

Recommended laboratory accessories

Description

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) approved for HIV-related lipodystrophy. Research shows significant visceral fat reduction and elevated IGF-1.

For research use only. Not for human consumption.

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin”

Your email address will not be published. Required fields are marked *

Related products